drugset / Trial / NCT01568489
Phase 2 Study of HL-009 Liposomal Gel to Treat Mild to Moderate Atopic Dermatitis
RandomizedParallel-groupDouble-blindTreatment
Summary
The objective of this phase 2 study is to evaluate the safety and efficacy of HL-009 Liposomal Gel in adult patients with mild to moderate atopic dermatitis (AD).
Timeline
- Start
- 2012-04-09
- Primary completion
- 2013-06-11
- Completion
- 2013-06-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cobamamide | Unknown | 0.07 % | Topical |
| Subject | Cobamamide | Unknown | 0.15 % | Topical |
| Subject | Cobamamide | Unknown | 0.3 % | Topical |